首页> 外文期刊>Cardiovascular Research >KCNQ1 autoantibodies: Another way to regulate IKs
【24h】

KCNQ1 autoantibodies: Another way to regulate IKs

机译:KCNQ1自身抗体:调节IK的另一种方法

获取原文
获取原文并翻译 | 示例
       

摘要

A subset of patients with dilated cardiomyopathy (DCM) have been shown to carry increased levels of autoantibodies against P-adrenoceptors, muscarinic receptors, Na~+-K~+-ATPase, or troponin I. There is increasing evidence thatthese autoantibodies can have important electro-physiological consequences and may contribute to the arrhythmogenic risk of DCM patients. In this edition of Cardiovascular Research, Li et al. identify another potential electrophysiological target of autoantibodies by showingthat a subset of patients with DCM has elevated autoantibodies against the extracellular pore region of KCNQ1,the alpha-subunitofthe slowly activating delayed rectifier K~+ current (I_(ks)). Anti-KCNQ1 autoantibodies, present in ~6% of DCM patients, increased I_(ks) in human embryonic kidney cells, and were associated with shortened QT intervals in seropositive patients. This interesting study adds important new insights to our understanding of the regulation and potential dysfunction of I_(ks).
机译:已显示一部分扩张型心肌病(DCM)患者携带针对P肾上腺素受体,毒蕈碱受体,Na〜+ -K〜+ -ATPase或肌钙蛋白I的自身抗体水平升高。越来越多的证据表明这些自身抗体可能具有重要的意义。电生理后果,可能会增加DCM患者的心律失常风险。在本版《心血管研究》中,Li等人。通过显示一部分DCM患者对KCNQ1胞外孔区域(缓慢激活的延迟整流器K〜+电流(I_(ks))的α亚基)的自身抗体升高,来确定自身抗体的另一个潜在电生理靶标。抗KCNQ1自身抗体存在于约6%的DCM患者中,其人类胚胎肾细胞中的I_(ks)增加,并且与血清反应阳性患者的QT间隔缩短有关。这项有趣的研究为我们对I_(ks)的调节和潜在功能障碍的理解增添了重要的新见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号